Volume 20, Number 11—November 2014
Letter
Antimicrobial Drug–Resistant Bacteria Isolated from Syrian War–Injured Patients, August 2011–March 2013
Table
Antimicrobial drug resistance among frequently isolated bacterial isolates from Syrian patients with war-associated wound infections, August 2011–March 2013*
Antimicrobial drug | No. MDR resistant isolates/no. total (%) |
|||
---|---|---|---|---|
Staphylococcus aureus, N = 19 | Pseudomonas aeruginosa, N = 10 | Escherichia coli, N = 8 | Acinetobacter baumannii, N = 6 | |
Amikacin | 1/ 11 (9) | 1/7 (14) | 6/6 (100) | |
Ampicillin | 5/5 (100) | |||
Amoxicillin/clavulanic acid | 6/6 (100) | |||
Cefotaxime | 6/8 (75) | |||
Ceftriaxone | 5/8 (62) | |||
Ceftazidime | 3/9 (33) | 5/8 (62) | 4/4 (100) | |
Cefepime | 5/8 (62) | 5/5 (100) | ||
Cefixime | 5/8 (62) | 5/5 (100) | ||
Ciprofloxacin | 7/17 (41) | 5/8 (62) | 2/7 (28) | 5/5 (100) |
Colistin | NA | NA | 0/5 | |
Trimethoprim/sulfamethoxazole | 3/14 (21) | 3/5 (60) | ||
Gentamicin | 10/18 (55) | 4/9 (44) | 4/8 (50) | 6/6 (100) |
Piperacillin/tazobactam | 2/9 (22) | 3/7 (42) | NA | |
Imipenem | 0/9 | 1/7 (14) | 4/5 (80) | |
Penicillin | 9/10 (90) | |||
Oxacillin | 7/17 (41) | |||
Clindamycin | 9/17 (52) | |||
Rifampin | 6/15 (40) | |||
Fusidic acid | 10/15 (66) |
*Blank cells indicate that testing was not done.